Behcet's disease and risk of vascular events

被引：20

作者：

Balta, Sevket ^{[1
]}

Balta, Ilknur ^{[2
]}

Ozturk, Cengiz ^{[1
]}

Celik, Turgay ^{[1
]}

Iyisoy, Atila ^{[1
]}

机构：

[1] Gulhane Mil Med Acad, Dept Cardiol, Ankara, Turkey

[2] Ankara Numune Training & Res Hosp, Dept Dermatol, Ankara, Turkey

来源：

CURRENT OPINION IN CARDIOLOGY | 2016年 / 31卷 / 04期

关键词：

Behcet's disease; thrombosis; vascular risk; ENDOTHELIAL GROWTH-FACTOR; INTIMA-MEDIA THICKNESS; CARDIOVASCULAR INVOLVEMENT; FACTOR-V; ASSOCIATION; ENDOCAN; MANIFESTATIONS; HOMOCYSTEINE; PROTHROMBIN; THROMBOSIS;

D O I：

10.1097/HCO.0000000000000281

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Purpose of reviewWe discuss the relationship between several factors and the risk of vascular events in patients with Behcet's disease.Recent findingsBehcet's disease, a systemic, chronic relapsing vasculitis, is mainly seen in the Mediterranean area and is typically characterized by recurrent oro-genital ulcers, ocular inflammation, and skin manifestations, including articular, vascular, gastroenteric, and neurological involvement. It is a chronic inflammatory disease with relapses and remissions. The prognosis varies. Behcet's disease can cause venous or arterial lesions. Vascular involvement contributes to the mortality and morbidity associated with Behcet's disease.SummaryThe cause of thrombosis or vascular events in Behcet's disease remains incompletely understood; several factors have been studied with conflicting results. Vasculitis is considered to underlie several clinical manifestations of Behcet's disease.

引用

页码：451 / 457

页数：7

共 47 条

[1] Behcet Disease With Vascular Involvement Effects of Different Therapeutic Regimens on the Incidence of New Relapses [J].

Alibaz-Oner, Fatma ;

Karadeniz, Asli ;

Yilmaz, Sema ;

Balkarli, Ayse ;

Kimyon, Gezmis ;

Yazici, Ayten ;

Cinar, Muhammet ;

Yilmaz, Sedat ;

Yildiz, Fatih ;

Bilge, Sule Yasar ;

Bilgin, Emre ;

Coskun, Belkis Nihan ;

Omma, Ahmet ;

Cetin, Gozde Yildirim ;

Cagatay, Yonca ;

Karaaslan, Yasar ;

Sayarlioglu, Mehmet ;

Pehlivan, Yavuz ;

Kalyoncu, Umut ;

Karadag, Omer ;

Kasifoglu, Timucin ;

Erken, Eren ;

Pay, Salih ;

Cefle, Ayse ;

Kisacik, Bunyamin ;

Onat, Ahmet Mesut ;

Cobankara, Veli ;

Direskeneli, Haner .

MEDICINE, 2015, 94 (06) :e494

[2]

Alkaabi Juma K, 2014, Sultan Qaboos Univ Med J, V14, pe190

[3] Mucocutaneous lesions of Behcet's disease [J].

Alpsoy, Erkan ;

Zouboulis, Christos Constantin ;

Ehrlich, George Edward .

YONSEI MEDICAL JOURNAL, 2007, 48 (04) :573-585

[4] Inflammation modulation and cardiovascular disease prevention [J].

Awan, Zuhier ;

Genest, Jacques .

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2015, 22 (06) :719-733

[5] Activated protein C resistance in Behcet's disease [J].

Abdel Badaee H. ;

Edrees A. ;

Amin S. ;

El Amir M. ;

Ragab G. .

Thrombosis Journal, 11 (1)

[6] Mean platelet volume is associated with aortic arterial stiffness in patients with Behcet's disease without significant cardiovascular involvement [J].

Balta, I. ;

Balta, S. ;

Koryurek, O. M. ;

Demirkol, S. ;

Celik, T. ;

Akbay, G. ;

Cakar, M. ;

Sarlak, H. ;

Eksioglu, M. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (10) :1388-1393

[7] Demographic and clinical features of 521 Turkish patients with Behcet's disease [J].

Balta, Ilknur ;

Akbay, Gulfer ;

Kalkan, Goknur ;

Eksioglu, Meral .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2014, 53 (05) :564-569

[8] Serum endocan levels as a marker of disease activity in patients with Behcet disease [J].

Balta, Ilknur ;

Balta, Sevket ;

Koryurek, Ozgul Mustu ;

Demirkol, Sait ;

Mikhailidis, Dimitri P. ;

Celik, Turgay ;

Cakar, Mustafa ;

Kucuk, Ugur ;

Eksioglu, Meral ;

Kurt, Yasemin Gulcan .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (02) :291-296

[9]

Balta S, 2015, CLIN APPL THROMB HEM

[10] Endocan, Obstructive Sleep Apnea, and Vascular Risk [J].

Balta, Sevket ;

Ozturk, Cengiz .

ANGIOLOGY, 2016, 67 (04) :305-306

← 1 2 3 4 5 →